Washington Growth Strategies Llc Portfolio Activity: Q2 2026 Insights

During the second quarter of 2026, Washington Growth Strategies Llc (institution profile) made several noteworthy changes to its portfolio. The firm's holdings saw adjustments across various sectors and asset classes during this period.

The investor primarily focused on buying new positions, with no disclosed large-scale selling activities according to the filing data. This quarter demonstrated a strategic inclination towards increasing exposure in certain areas while maintaining existing allocations where appropriate.

Prominent Purchases

Washington Growth Strategies Llc significantly increased its stake in several individual stocks during Q2 2026:

• NVIDIA Corporation (NVDA), a Technology company, saw an increase of approximately 73.34% in its position.
• There was a substantial purchase of shares in Johnson & Johnson (JNJ), the healthcare giant, representing an increase from prior period holdings by about 100%.
• The firm also notably added to its position in Gilead Sciences Inc. (GILD), increasing shares by roughly 100%.
• Additionally, Washington Growth Strategies Llc purchased a significant amount of Thermo Fisher Scientific Inc. (TMO), boosting its stake in the Healthcare sector by approximately 100%.

Furthermore, the investor showed strong interest in other companies through new positions:

• NVIDIA Corporation (NVDA), Technology.
• Johnson & Johnson (JNJ), Healthcare.
• Gilead Sciences Inc. (GILD), Healthcare.
• Thermo Fisher Scientific Inc. (TMO), Healthcare.

Minor Adjustments and Reductions

Beyond the significant buys, Washington Growth Strategies Llc also made some smaller adjustments to its holdings:

• The investor slightly increased its position in Vanguard ETF Trust (VO), a Technology holding.
• There was a modest increase in Vaneck ETF Trust (GLIN) as well, though the allocation remains small.

Conversely, some holdings saw minor reductions:

• The investor decreased its position in Vanguard World Fund (VHT), reducing shares by about 4.67% compared to the prior period.
• Shares of Pave ETF Trust (PAVE) were reduced slightly, down by approximately 0.61% in terms of portfolio allocation.
• The position in Vanguard Index Fund Trust (VNQ) was also decreased modestly.

These minor adjustments suggest a level of fine-tuning to the existing portfolio structure:

• Pave ETF Trust (PAVE)
• Vanguard World Fund (VHT)

Overall Portfolio Changes

The total portfolio value for Washington Growth Strategies Llc stood at $178,723,763 as of June 30th, 2026. The changes observed in the holdings indicate a dynamic quarter with strategic buying focused on specific growth areas.